These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11347055)

  • 21. [Lipid disorders in liver diseases].
    Studeník P
    Vnitr Lek; 2000 Sep; 46(9):547-8. PubMed ID: 11344649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress.
    Serviddio G; Pereda J; Pallardó FV; Carretero J; Borras C; Cutrin J; Vendemiale G; Poli G; Viña J; Sastre J
    Hepatology; 2004 Mar; 39(3):711-20. PubMed ID: 14999689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: cholesterol absorption and synthesis related to lipoprotein levels and their kinetics.
    Gylling H; Färkkilä M; Vuoristo M; Miettinen TA
    Hepatology; 1995 Jan; 21(1):89-95. PubMed ID: 7806174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Catabolism of lipoprotein-X (Lp-X) induced by infusion of 10% intralipid].
    Abe M; Tashiro T; Mashima Y; Yamamori H; Nishizawa M; Sanada M; Okui K
    Nihon Geka Gakkai Zasshi; 1991 Dec; 92(12):1678-85. PubMed ID: 1809875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary biliary cirrhosis: management of an unusual case with severe xanthomata by hepatic transplantation.
    Peters MG; Hoffnagle JH; McGarvey C; Fox I; Gregg RE; Jones EA
    J Clin Gastroenterol; 1989 Dec; 11(6):694-7. PubMed ID: 2584673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of aerobic exercise and ginsenosides on lipid metabolism in diet-induced hyperlipidemia mice.
    Yang Y; Wu T; He K; Fu ZG
    Zhongguo Yao Li Xue Bao; 1999 Jun; 20(6):563-5. PubMed ID: 10678155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein-X disease in the setting of severe cholestatic hepatobiliary autoimmune disease.
    Heinl RE; Tennant HM; Ricketts JC; Rice CR; Robinson CB; Sandesara PB; Moriarty PM; Sperling L
    J Clin Lipidol; 2017; 11(1):282-286. PubMed ID: 28391896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of lipoprotein-X in the pathogenesis of cholestatic hypercholesterolemia. Uptake of lipoprotein-X and its effect on 3-hydroxy-3-methylglutaryl coenzyme A reductase and chylomicron remnant removal in human fibroblasts, lymphocytes, and in the rat.
    Walli AK; Seidel D
    J Clin Invest; 1984 Sep; 74(3):867-79. PubMed ID: 6470142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pathophysiology and clinical aspects of intrahepatic cholestasis].
    Kühn HA; Richter E
    Med Klin; 1970 Jan; 65(1):1-8. PubMed ID: 4929317
    [No Abstract]   [Full Text] [Related]  

  • 30. [The diagnostic significance of lipoprotein-X].
    Radzevich IM; Gromashevskaia LL; Tat'ianko NV
    Vrach Delo; 1990 Jan; (1):116-9. PubMed ID: 2330694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Water-soluble extract of Coleus barbatus modulates weight gain, energy utilization and lipid metabolism in secondary biliary cirrhosis: an experimental study in young rats.
    Battochio AP; Sartori MS; Coelho CA
    Acta Cir Bras; 2005; 20(3):229-36. PubMed ID: 16033182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of an intact cholesterol feedback mechanism in the liver in biliary stasis.
    Weis HJ; Dietschy JM
    Gastroenterology; 1971 Jul; 61(1):77-84. PubMed ID: 5088529
    [No Abstract]   [Full Text] [Related]  

  • 33. LP-X in cholestasis.
    Tanno H; Fay O; Palazzi J; Pedrana R; Yäger E; Roncoroni M
    Acta Hepatogastroenterol (Stuttg); 1975 Oct; 22(5):289-91. PubMed ID: 173123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Viral origin of certain cases of chronic intrahepatic cholestasis: a case of hypercholostatic and hyperlipidemic jaundice evolving towards a chronic condition].
    Albot G; Camilleri JP; Reynes M
    Sem Hop; 1973 Dec; 49(52):3481-95. PubMed ID: 4365823
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cholesterol metabolism disorders in digestive pathology. II].
    Rautureau J; Coste T; Rautureau M
    Arch Fr Mal App Dig; 1972 Aug; 61(8):497-506. PubMed ID: 4567365
    [No Abstract]   [Full Text] [Related]  

  • 36. Acetate 14C incorporation in hepatic and plasmatic cholesterol during triton-induced hyperlipemia.
    Breillot J; Fourçans B; Melin B; Piot MC; Alcindor LG; Polonovski J
    Steroids Lipids Res; 1974; 5(2):96-100. PubMed ID: 4428494
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of ginsenoside-Rb on blood lipid metabolism and anti-oxidation in hyperlipidemia rats].
    Zhang XM; Qu SC; Sui DY; Yu XF; Lv ZZ
    Zhongguo Zhong Yao Za Zhi; 2004 Nov; 29(11):1085-8. PubMed ID: 15656146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lipoprotein metabolism in the blood plasma and liver in alimentary dyslipoproteinemias in an experiment].
    Liapkov BG
    Vopr Pitan; 1985; (5):32-7. PubMed ID: 4082518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fat metabolism and the liver].
    Gros H
    Med Klin; 1973 Aug; 68(32):1021-4. PubMed ID: 4582296
    [No Abstract]   [Full Text] [Related]  

  • 40. High incidence of poor sulfoxidation in patients with primary biliary cirrhosis.
    Olomu AB; Vickers CR; Waring RH; Clements D; Babbs C; Warnes TW; Elias E
    N Engl J Med; 1988 Apr; 318(17):1089-92. PubMed ID: 3281015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.